COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review

There are limited clinical data on the impact of the SARS-CoV2 infection on patients with dermatological conditions treated with biologics. Dupilumab is a recombinant human IgG(4) human monoclonal antibody that inhibits IL4 and IL13 signaling, and is used for moderate–severe atopic dermatitis treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceryn, Justyna, Niedźwiedź, Michał, Skibińska, Małgorzata, Ciążyńska, Magdalena, Lesiak, Aleksandra, Narbutt, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407774/
https://www.ncbi.nlm.nih.gov/pubmed/34475772
http://dx.doi.org/10.2147/CCID.S321003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407774/
https://www.ncbi.nlm.nih.gov/pubmed/34475772
http://dx.doi.org/10.2147/CCID.S321003

Ejemplares similares